173 related articles for article (PubMed ID: 30217817)
1. Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation.
Regeenes R; Silva PN; Chang HH; Arany EJ; Shukalyuk AI; Audet J; Kilkenny DM; Rocheleau JV
J Biol Chem; 2018 Nov; 293(44):17218-17228. PubMed ID: 30217817
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new fibroblast growth factor receptor, FGFR5.
Sleeman M; Fraser J; McDonald M; Yuan S; White D; Grandison P; Kumble K; Watson JD; Murison JG
Gene; 2001 Jun; 271(2):171-82. PubMed ID: 11418238
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor like-1 (FGFRL1) interacts with SHP-1 phosphatase at insulin secretory granules and induces beta-cell ERK1/2 protein activation.
Silva PN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2013 Jun; 288(24):17859-70. PubMed ID: 23640895
[TBL] [Abstract][Full Text] [Related]
4. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
5. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
6. Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.
Comps-Agrar L; Dunshee DR; Eaton DL; Sonoda J
J Biol Chem; 2015 Oct; 290(40):24166-77. PubMed ID: 26272615
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
8. Laminin matrix regulates beta-cell FGFR5 expression to enhance glucose-stimulated metabolism.
Pal V; Wang Y; Regeenes R; Kilkenny DM; Rocheleau JV
Sci Rep; 2022 Apr; 12(1):6110. PubMed ID: 35414066
[TBL] [Abstract][Full Text] [Related]
9. A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1).
Kim I; Moon S; Yu K; Kim U; Koh GY
Biochim Biophys Acta; 2001 Mar; 1518(1-2):152-6. PubMed ID: 11267671
[TBL] [Abstract][Full Text] [Related]
10. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
11. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
Kilkenny DM; Rocheleau JV
Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1.
Amann R; Trueb B
Int J Mol Med; 2013 Nov; 32(5):983-8. PubMed ID: 24026051
[TBL] [Abstract][Full Text] [Related]
13. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
Chen G; Wang J; Liu Z; Kornmann M
Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
[TBL] [Abstract][Full Text] [Related]
14. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
Tian X; Chen G; Zhou S; Henne-Bruns D; Bachem M; Kornmann M
Hepatogastroenterology; 2012; 59(117):1604-8. PubMed ID: 22683979
[TBL] [Abstract][Full Text] [Related]
15. Number and brightness analysis reveals that NCAM and FGF2 elicit different assembly and dynamics of FGFR1 in live cells.
Zamai M; Trullo A; Giordano M; Corti V; Arza Cuesta E; Francavilla C; Cavallaro U; Caiolfa VR
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30478195
[TBL] [Abstract][Full Text] [Related]
16. Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.
Kähkönen TE; Ivaska KK; Jiang M; Büki KG; Väänänen HK; Härkönen PL
Mol Cell Endocrinol; 2018 Feb; 461():194-204. PubMed ID: 28923346
[TBL] [Abstract][Full Text] [Related]
17. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
19. Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2.
Borroto-Escuela DO; Corrales F; Narvaez M; Oflijan J; Agnati LF; Palkovits M; Fuxe K
Biochem Biophys Res Commun; 2013 Nov; 441(2):387-92. PubMed ID: 24157794
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
